Catheter Precision Corporation (VTAK) - Forward Price-to-Revenue Multiple

Corporate emblem and logo of Catheter Precision, Inc. (VTAK)

Catheter Precision revenues are based on the sale of electrophysiological mapping systems and catheter management. The forward price-to-sales ratio reflects the dynamics of this process, where 1.50 becomes the new value of the metric. Growth is supported by the implementation of VIVO 3D mapping and expansion into the EU. Meanwhile, Catheter Precision strictly adheres to RoHS standards, ensuring the sterility of medical instrument production.

VTAK Catheter Precision, Inc.: Future Price to Revenue in the range 02/21/2024 - 10/05/2026

VTAK (Catheter Precision Corporation): analytical breakdowns and indicator data

- market price and analyst price targets:
Price Chart Catheter Precision, Inc.|VTAK - Fair Value Consensus
- market capitalization indicators:
Market Valuation Catheter Precision Corporation|VTAK - Value Adjusted for Debt and Cash
- business book valuation details:
Net Assets per Single Share Catheter Precision|VTAK - Net Asset Value|Market Value to Book Value Ratio catheterprecision.com|VTAK - Aggregate Asset Value
- debt and solvency information:
Total Debt to Capital Catheter Precision|VTAK - Long-Term Liabilities to Capital|Short-Term Debt to Capital Catheter Precision|VTAK - Company Total Debt|Debts to Book Capitalization Catheter Precision Corporation|VTAK - Long-Term Debt Volume|Company Short-Term Debt Catheter Precision|Quick Ratio catheterprecision.com
- business earnings and investment ratios data:
VTAK - Net Financial Result|Expected Profit Catheter Precision|VTAK - Market Cap to Earnings|Future Price to Earnings Catheter Precision Corp|VTAK - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Catheter Precision Corporation|VTAK - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Catheter Precision|VTAK - Earnings per share for the last four quarters|Quarterly EPS earnings growth catheterprecision.com|VTAK - Earnings growth in current year|Net earnings per share growth forecast for next year Catheter Precision
- sales volume and revenue information:
VTAK - Revenue and Sales Volume|Projected Sales Volume Catheter Precision, Inc.|VTAK - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Catheter Precision Corporation
Analysis of all company metrics:Catheter Precision, Inc. VTAK
Product sample of Catheter Precision Corporation

The forward P/S ratio correlates the current market value of Catheter Precision (VTAK) with projected annual revenue, allowing for an assessment of the premium paid for future cash flows. By analyzing the projected P/S trend, an investor can determine the fairness of the valuation for a business whose financial growth depends on the demand for high-margin robotic catheters and VMAP arrhythmia mapping systems.

Analysis of competing companies

Price-to-Projected Revenue Ratio Regeneron REGN|Forward Price to Sales IRTC|LNTH: Forward Price-to-Revenue Multiple|Forward Price to Sales MLYS (Mineralys Corp)|heartflow.com (HTFL) - Price-to-Projected Revenue Ratio|Future Price to Revenue KMTS (kestramedical.com)|Price-to-Projected Revenue Ratio Esperion|AMRN: Forward Price to Sales|Forward P/S Multiple AVR|TNYA - Market Cap to Future Revenue Ratio|Forward P/S Multiple CVRX (CVRx, Inc.)|MIST - Forward Price-to-Revenue Multiple|Cardiol - Forward P/S Multiple|Market Cap to Expected Sales Ratio HeartBeam Inc BEAT|Tenax Therapeutics, Inc (TENX) - Price-to-Projected Revenue Ratio|ADGM - Market Cap to Expected Sales Ratio|BCDA (BioCardia, Inc.) - Forward P/S Multiple|ARCA Bio (ABIO) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Acasti Pharma (ACST)|AVTE - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Verve Therapeutics, Inc. VERV|WINT: Market Cap to Projected Revenue